Citation

Krueger RB, Hembree W, Hill M. Sex. Abuse 2006; 18(2): 227-228.

Affiliation

Department of Psychiatry, Columbia University, College of Physicians and Surgeons, and Medical Director, Sexual Behavior Clinic, New York State Psychiatric Institute, Unit #45, 1051 Riverside Drive, New York, NY 10032, USA. rbk1@columbia.edu

Copyright

(Copyright © 2006, SAGE Publishing)

DOI

10.1007/s11194-006-9012-5

PMID

16868842

Abstract

This article provides a case report of a patient with pedophilia who was treated over a 4-year period with medroxyprogesterone acetate (MPA) at a dose of 300 mg/day and as a consequence developed Cushing's Syndrome and adrenal insufficiency, for which he was treated and from which he recovered. He also reported a hypersexual reaction to his own past cessation of MPA. Gonadotropin-releasing hormone agonists, which have a more benign side-effect profile than MPA, are suggested as an alternative to MPA.

Language: en